ArticleFrontiers in endocrinology2026
Patient-reported outcomes in adults with type 3c diabetes: a scoping review across aetiologies and pancreatic resection extent.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 3c diabetes is a heterogeneous secondary diabetes caused by pancreatic disease, injury or resection. Glycaemic outcomes alone do not capture the combined effects of insulin deficiency, impaired counter-regulation, exocrine insufficiency, pain, altered nutrition and treatment burden. We mapped standardized patient-reported outcome measures (PROMs) across aetiologies and pancreatic resection extent. Methods: MEDLINE via PubMed, Scopus and Web of Science Core Collection were searched from inception to 23-24 July 2026, supplemented by public trial registries and targeted citation checking. A scoping review framed by Population-Concept-Context followed JBI guidance and PRISMA-ScR. An automation-assisted title/abstract pathway was followed by independent report-level adjudication by two reviewers. Results: The searches yielded 5,132 records and 3,372 unique database records after deduplication. Fifty-six reports underwent independent report-level adjudication; one was not retrieved, 15 were excluded and 40 were included. In a reproducible Conclusions: Patient-reported burden in type 3c diabetes is multidimensional and measurement remains fragmented. Future studies should combine complementary measures and report aetiology, diabetes timing and total versus partial resection explicitly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.